Study of NTX-1472 for social anxiety disorder
Part of Mental health clinical trials.
This trial tests an investigational medicine called NTX-1472 to see if it helps people with social anxiety disorder. Participation involves taking the study drug and attending scheduled visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have a diagnosis of generalized social anxiety disorder (not just performance anxiety).
- Your social anxiety symptoms must be at least moderately severe based on a standard rating scale.
- You cannot have major depression, bipolar disorder, OCD, PTSD, or other serious mental health conditions.
- You must not be taking daily psychiatric medications within 4 weeks of starting the study.
- If you can become pregnant, you must agree to use effective birth control during the study and for 2 weeks after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the medication caplyta (lumateperone) helps reduce symptoms of social anxiety disorder compared to a placebo. If it works, it could give people a new treatment option.
This study tests if a non-invasive brain stimulation technique called theta burst stimulation can help treat social anxiety disorder. It uses magnetic pulses to target a brain area involved in fear and anxiety, and you may benefit if you have social anxiety and are not taking certain medications.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This trial is testing a new medicine, NTX-253, to see how safe it is and how the body processes it. It is for healthy adults and adults with schizophrenia whose symptoms are stable on their current treatment.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
This study tests a new drug, SBS-147, in healthy adults to see if it's safe and how the body processes it. It may help find the right dose for future studies in people with certain conditions.
Hear when a new Social Anxiety Disorder (SAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.